COMPANY
Abreos Biosciences, Inc.
ABREOS BIOSCIENCES, INC. has received NIH funding, most recently in fiscal 2020 for the project “Personalized precision dosing of anti-TNF biologic therapies”. From public records Source · Oct 12, 2026
COMPANY
ABREOS BIOSCIENCES, INC. has received NIH funding, most recently in fiscal 2020 for the project “Personalized precision dosing of anti-TNF biologic therapies”. From public records Source · Oct 12, 2026